Study of Inborn Errors of Cholesterol Synthesis and Related Disorders
Investigations Into Inborn Errors of Cholesterol Synthesis and Related Disorders
2 other identifiers
observational
342
1 country
1
Brief Summary
This study will investigate the cause and medical problems associated with a group of genetic disorders known as inborn errors of cholesterol synthesis, in which the body does not produce cholesterol. People with this disorder may have birth defects and learning and behavioral problems. People with an inborn error of cholesterol synthesis and related disorders, including Smith-Lemli-Opitz syndrome, lathosterolosis, desmosterolosis, X-linked dominant chondrodysplasia, CHILD syndrome, Greenberg dysplasia, and some cases of Antley-Bixler syndrome, may be eligible for this study. People who are carriers of the disorders also may enroll. Participants and family members will provide blood and urine samples, as well as other tissue samples collected during medically indicated procedures such as biopsy or surgery. These tissues may include, for example, gallstones, cataracts, cerebrospinal fluid, amniotic fluid, lymph tissue, and DNA samples. In rare instances, a skin biopsy may be requested to aid in establishing a diagnosis. Medical information will also be gathered from medical records, photographs, and X-rays.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2002
CompletedFirst Posted
Study publicly available on registry
September 23, 2002
CompletedStudy Start
First participant enrolled
October 9, 2002
CompletedApril 1, 2026
September 26, 2025
September 21, 2002
March 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
sample collection
collect sample to study rare manifestations or disease
event driven upon enrollment
Study Arms (2)
normal subjects
subjects in whom no disorder of cholesterol is suspected related to affected individuals
subjects suspected of cholesterol disorder
subjects in whom a disorder of cholesterol metabolism is suspected
Eligibility Criteria
Convenience sampling: affected patients and their relatives, samples from biorepositories
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Publications (3)
Kelley RI, Hennekam RC. The Smith-Lemli-Opitz syndrome. J Med Genet. 2000 May;37(5):321-35. doi: 10.1136/jmg.37.5.321.
PMID: 10807690BACKGROUNDNwokoro NA, Wassif CA, Porter FD. Genetic disorders of cholesterol biosynthesis in mice and humans. Mol Genet Metab. 2001 Sep-Oct;74(1-2):105-19. doi: 10.1006/mgme.2001.3226.
PMID: 11592808BACKGROUNDKelley RI, Kratz LE, Glaser RL, Netzloff ML, Wolf LM, Jabs EW. Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. Am J Med Genet. 2002 Jun 15;110(2):95-102. doi: 10.1002/ajmg.10510.
PMID: 12116245BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Forbes D Porter, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2002
First Posted
September 23, 2002
Study Start
October 9, 2002
Last Updated
April 1, 2026
Record last verified: 2025-09-26
Data Sharing
- IPD Sharing
- Will not share
Data will be shared in aggregate related to the disorders represented by accrual.